SCHEMBL7145103

SCHEMBL7145103

[CH2]CCc1ccccc1S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 4/20 0.39
ADRA1A P35348 3/20 0.39
ADRA1B P35368 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC6A2 P23975 1/20 0.39
CTSB P07858 1/20 0.36
LOX P28300 1/20 0.36
BCAT2 O15382 1/20 0.35
DRD2 P14416 1/20 0.35
MPO P05164 1/20 0.35
NR3C1 P04150 1/20 0.35
NQO2 P16083 1/20 0.34
P2RX7 Q99572 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2045171 0.89 ADRA1D (0.41) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL2542665 0.83 MEN1 (0.41) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL10181521 0.82 DRD2 (0.42) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL7623115 0.80 MEN1 (0.42) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL8337031 0.80 TAAR1 (0.50) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL17848762 0.80 MEN1 (0.42) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL27961328 0.80 ADRA1D (0.39) ADRA1DADRA1AADRA1BMEN1CYP1A2
SCHEMBL3061453 0.79 ADRA2A (0.36) ADRA1DADRA1AADRA1BCYP1A2CYP2C19
SCHEMBL2024322 0.79 CTSB (0.53) ADRA1DMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL10180158 0.78 ADRA1D (0.42) ADRA1DADRA1AADRA1BMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003518095-A 2003-06-03 JP claimed
EP-1240142-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. Carlsson Research AB (SE) 2002-09-18 EP claimed
WO-2001046145-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2001-06-28 WO claimed
EP-3504187-A1 USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE Prilenia Therapeutics Development Ltd. (IL) 2019-07-03 EP disclosed
EP-3503890-A1 USE OF PRIDOPIDINE FOR TREATING DYSTONIAS Prilenia Therapeutics Development Ltd. (IL) 2019-07-03 EP disclosed
WO-2018039475-A1 USE OF PRIDOPIDINE FOR TREATING DYSTONIAS TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) 2018-03-01 WO disclosed
WO-2018039477-A1 USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) 2018-03-01 WO disclosed
CN-100345833-C Modulators of dopamine neurotransmission CARLSSON RES AB (SE) 2007-10-31 CN disclosed
CN-1255382-C Novel modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2006-05-10 CN disclosed
CN-1765890-A Modulators of dopamine neurotransmission CARLSSON RES AB (SE) 2006-05-03 CN disclosed
CN-1420869-A Novel modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2003-05-28 CN disclosed
EP-1240142-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. Carlsson Research AB (SE) 2002-09-18 EP disclosed
WO-2001046145-A1 NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION A. CARLSSON RESEARCH AB (SE) 2001-06-28 WO disclosed